$50.21 0.37 (+0.74%)
2/13/2012 4:02 PM

Smith & Nephew plc (ADR) (NYSE:SNN)

CAPS Rating: 4 out of 5

The Company is a global business engaged in the development, manufacture and marketing of medical devices in the sectors of orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management.

Recs

0
Player Avatar Jstaple7 (< 20) Submitted: 2/26/2008 4:53:29 PM : Outperform Start Price: $62.18 SNN Score: -21.80

Great growth stock as the ortho company has increased market share each year. They continue to pressure leading competitors Zimmer and Stryker and are poised to overtake Zimmer in 2010.

They have addressed their inventory concerns from 2006 and are continuing to implement full lean processes. The SAP conversion from previously outdated BPCS will only aid in the management of their inventories.

Report this Post Add Comment

Featured Broker Partners


Advertisement